Accelerative Solid-State Oxidation Behaviour of Amorphous and Partially Crystalline Venetoclax.
AAPS PharmSciTech
; 25(5): 114, 2024 May 15.
Article
em En
| MEDLINE
| ID: mdl-38750299
ABSTRACT
There is a growing focus on solid-state degradation, especially for its relevance in understanding interactions with excipients. Performing a solid-state degradation of Venetoclax (VEN), we delve into VEN's stability in different solid-state oxidative stress conditions, utilizing Peroxydone™ complex and urea peroxide (UHP). The investigation extends beyond traditional forced degradation scenarios, providing insights into VEN's behavior over 32 h, considering temperature and crystallinity conditions. Distinct behaviors emerge in the cases of Peroxydone™ complex and UHP. The partially crystalline (PC-VEN) form proves more stable with Peroxydone™, while the amorphous form (A-VEN) shows enhanced stability with UHP. N-oxide VEN, a significant degradation product, varies between these cases, reflecting the impact of different oxidative stress conditions. Peroxydone™ complex demonstrates higher reproducibility and stability, making it a promising option for screening impurities in solid-state oxidative stress scenarios. This research not only contributes to the understanding of VEN's stability in solid-state but also aids formulators in anticipating excipient incompatibilities owing to presence of reactive impurities (peroxides) and oxidation in the final dosage form.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oxirredução
/
Sulfonamidas
/
Compostos Bicíclicos Heterocíclicos com Pontes
/
Cristalização
/
Estabilidade de Medicamentos
/
Excipientes
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article